The Hours Conversation Has Changed
Twelve months ago, a payer pushback on authorized ABA hours was a billing inconvenience. Today it’s an existential conversation.
Nebraska capped ABA at 30 hours per week and cut rates by up to 48%. Indiana imposed its own hour caps. New York has legislation proposing 680-hour annual limits. North Carolina’s legislature just held a hearing where a senator asked if the state should pause Medicaid ABA entirely. Centene’s ABA task force is flagging providers who prescribe maximum hours across their caseload.
The pressure to reduce hours is coming from every direction — legislative, regulatory, and payer. And the response from most practices is to absorb the cuts, appeal on a case-by-case basis, and hope it stabilizes.
That’s not a strategy. The data to defend intensive ABA exists. Most practices aren’t using it.
What the Research Actually Says
In 2025, the Council of Autism Service Providers (CASP) published an evidence paper that should be in every BCBA’s authorization toolkit. It synthesizes decades of research on the relationship between ABA treatment intensity and outcomes for young children with autism. The headline findings:
Children receiving 30+ hours of weekly ABA are twice as likely to close cognitive development gaps compared to children receiving fewer than 12 hours.
Children receiving 30+ hours are three times more likely to achieve everyday functional skills — successful communication, participation in home life, daily living independence — compared to the low-intensity group.
These aren’t anecdotal improvements. They’re measured using standardized instruments — Vineland Adaptive Behavior Scales, IQ assessments, and the Childhood Autism Rating Scale — across controlled comparisons of intensity groups.
The Meta-Analysis Behind the Numbers
The core of CASP’s evidence paper draws on a meta-analysis by Dr. Sigmund Eldevik and colleagues that controlled for treatment intensity across three groups:
| Intensity Level | Weekly Hours | Description |
|---|---|---|
| Low | 5–12 hours | Focused or limited treatment |
| Intermediate | 13–25 hours | Moderate comprehensive treatment |
| High | 26–40 hours | Early intensive behavioral intervention |
The analysis covered 341 children and measured outcomes using the Vineland Adaptive Behavior Composite (ABC), IQ, and CARS. For each measure, average improvement was consistently and significantly related to average intensity.
The most striking finding: the percentage of children who moved into the non-clinical range (standard score above 85) after high-intensity treatment was nearly three times the percentage increase after low-intensity treatment. That’s not a marginal difference. It’s a different outcome trajectory entirely.
And these gains persist. Smith et al. (2021) found that treatment gains from early intensive behavioral intervention were maintained 10 years later. The investment in intensive early treatment isn’t just producing short-term improvements — it’s changing long-term developmental trajectories.
What CASP Does and Doesn’t Say About 40 Hours
CASP’s practice guidelines do not make a blanket recommendation of 40 hours per week for every child. This is an important distinction because payers — and Centene’s task force specifically — have flagged “maximum hours for every patient” as a red flag.
What CASP does say is that there’s a proven correlation between higher numbers of ABA hours and better outcomes for young children with autism, and that the 0-to-6 developmental window is critical. Their position: treatment intensity should be determined by individual clinical assessment, but clinicians and payers should understand that reducing hours comes with measurable cost to outcomes.
Dr. Jane Howard, one of the paper’s contributors, put it plainly: “The conclusions couldn’t be clearer. The more hours of quality ABA a child receives in their earliest years of life, the better their outcomes are going to be.”
The distinction between “this child needs 35 hours based on clinical assessment” and “every child gets 40 hours” isn’t just semantic. It’s the difference between a defensible authorization request and a pattern that triggers a utilization review.
The Tension Between Data and the Current Environment
Here’s the uncomfortable reality practice owners are navigating: the research supports intensive treatment, but the policy environment is moving to limit it.
Payers see aggregate utilization data showing providers prescribing 30-40 hours for nearly every client and conclude that treatment isn’t individualized. States see spending growth of 300-400% and conclude that something is systemically wrong. OIG auditors see session notes that don’t match CPT codes and conclude that claims are improper.
None of these conclusions require the therapy itself to be ineffective. They require the documentation, individualization, and accountability infrastructure to be inadequate.
This is the gap most practices fall into. They deliver quality intensive ABA. They know the hours are clinically justified. But they can’t prove it in the format payers and auditors require — because the measurement systems aren’t there.
As we covered in our post on the shift from growth to proof, the practices that survive this transition will be the ones that can connect hours to outcomes with data, not anecdotes.
How to Use This Research Practically
The CASP evidence paper isn’t just an industry advocacy document. It’s a clinical tool. Here’s how to put it to work:
In Authorization Requests
When requesting 25+ hours per week, your authorization documentation should:
- Reference the specific clinical assessment findings that justify the intensity level
- Cite the Eldevik et al. meta-analysis showing the dose-response relationship between intensity and outcomes
- Include the child’s current standardized assessment scores (Vineland, VB-MAPP, or ABLLS-R) and the gap between those scores and age-appropriate norms
- Define specific, measurable goals that the requested hours are designed to achieve
- Include the CASP practice guidelines as a supporting reference for the treatment plan’s intensity recommendation
Payer reviewers respond to clinical data. “This child needs 30 hours” is a statement. “This child’s Vineland composite is 62, the age-appropriate norm is 100, the Eldevik meta-analysis demonstrates that high-intensity treatment is 2x more likely to close this gap, and our treatment plan targets these 12 specific skills across communication, daily living, and socialization domains” is an argument.
In Authorization Appeals
When hours are denied or reduced, the appeal should include:
- The CASP evidence paper citation with the specific 2x/3x outcome data
- The child’s progress data showing response to current intensity
- A clinical explanation of why reducing hours would compromise specific treatment goals
- Comparison data: if the child has been at higher intensity and progressing, a reduction risks the documented trajectory
In Payer Conversations
When payers push back on your practice’s overall utilization patterns:
- Demonstrate that treatment plans are individually derived, not templated
- Show variation in your caseload’s authorized hours — if every client is at 35-40 hours, that pattern invites scrutiny regardless of individual justifications
- Present aggregate outcomes data showing that your clients at higher intensity are making measurable progress
- Reference the 10-year maintenance data from Smith et al. (2021) — intensive early treatment doesn’t just produce short-term gains, it reduces the total lifetime cost of care
The Practices That Win Both Conversations
There are two conversations happening simultaneously in ABA right now, and they sound contradictory:
Conversation 1: “Intensive ABA works. The data is clear. Don’t let payers cut hours.”
Conversation 2: “Providers are prescribing maximum hours for everyone and can’t demonstrate outcomes. Hours need to be cut.”
Both conversations are correct — they’re just talking about different practices.
The practices that win are the ones that can participate in both conversations authentically. Yes, we provide intensive treatment — because the evidence supports it and because our clinical assessments indicate it. And yes, we can prove that the hours we’re delivering are producing measurable outcomes — because we track them systematically.
The CASP evidence paper gives you the clinical foundation. But the foundation only holds if your practice’s data backs it up. Individualized treatment plans. Standardized assessments on schedule. Outcomes tracking across the caseload. Documentation that matches every CPT code. Supervision that’s meaningful, not minimal.
The research defends intensive ABA. Your systems are what prove you’re delivering it.
Want to talk about how to build outcomes data into your authorization workflow? Reach out at [email protected] — we can help.
